
{{Infobox United States federal proposed legislation
| name =
| fullname        = To advance the public health by encouraging independent innovators to pursue drug repurposing research and develop new treatments and cures by providing appropriate intellectual property protections for those innovations, and for other purposes.
| acronym         =
| nickname        =
| introduced in the = 113th
| introduceddate   =
| sponsored by    = [[Richard_Blumenthal|Sen. Richard Blumenthal (D, CT)]]
| number of co-sponsors = 1
| public law url  =
| cite public law =
| cite statutes at large =
| acts affected =
| acts repealed   =
| title affected   =
| sections created =
| sections affected = {{USC|42|262}}, {{USC|35|154}}, {{USC|42|sec.}}, {{USC|35|156}}, {{USC|21|355}}, and others.
| agenciesaffected = [[Patent and Trademark Office/Under Secretary for Intellectual Property]], [[Food and Drug Administration]]
| authorizationsofappropriations =
| appropriations =
| leghisturl      =
| introducedin    = Senate
| introducedbill  = {{USBill|113|s|2150}}
| introducedby    = [[Richard_Blumenthal|Sen. Richard Blumenthal (D, CT)]]
| introduceddate  = March 24, 2014
| committees      = [[United States Senate Committee on the Judiciary]]
| passedbody1     =
| passeddate1     =
| passedvote1     =
| passedbody2     =
| passedas2       =
| passeddate2     =
| passedvote2     =
| conferencedate  =
| passedbody3     =
| passeddate3     =
| passedvote3     =
| agreedbody3     =
| agreeddate3     =
| agreedvote3     =
| agreedbody4     =
| agreeddate4     =
| agreedvote4     =
| passedbody4     =
| passeddate4     =
| passedvote4     =
| signedpresident =
| signeddate      =
| unsignedpresident =
| unsigneddate    =
| vetoedpresident =
| vetoeddate      =
| overriddenbody1 =
| overriddendate1 =
| overriddenvote1 =
| overriddenbody2 =
| overriddendate2 =
| overriddenvote2 =
| amendments      =
| SCOTUS cases    =
}}
++++++++++++++++++++++++++++++




Acts impacted, by reference count:


Sections impacted, by reference count:
	3:	{{USC|42|262}}
	1:	{{USC|35|154}}
	1:	{{USC|42|sec.}}
	1:	{{USC|35|156}}
	1:	{{USC|21|355}}

-30-